Plasma cell dyscrasias, monoclonal B cell lymphocytosis, and multiple myeloma are common in VEXAS patients, even though VEXAS patients commonly exhibit B cell lymphocytopenia and their B cells rarely harbor the UBA1 mutations1,11. This evidence concerns the gene UBA1 and monoclonal B-cell lymphocytosis.